Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs
Open accessAbstract
BACKGROUND: People who take analgesic drugs frequently may be at increased risk of end-stage renal disease (ESRD), but the extent of this risk remains unclear. METHODS: We studied 716 patients treated for ESRD and 361 control subjects of similar age from Maryland, Virginia, West Virginia, and Washington, D.C. The study participants were interviewed by telephone about their past use of medications containing acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (NSAIDs). For each analgesic drug, the average use (in pills per year) and the cumulative intake (in pills) were examined for any association with ESRD. RESULTS: Heavier acetaminophen use was associated with an increased risk of ESRD in a dose-dependent fashion. When persons who took an average of 0 to 104 pills per year were used for reference, the odds ratio of ESRD was 1.4 (95 percent confidence interval, 0.8 to 2.4) for those who took 105 to 365 pills per year and 2.1 (95 percent confidence interval, 1.1 to 3.7) for those who took 366 or more pills per year, after adjustment for race, sex, age, and intake of other analgesic drugs. When persons who had taken fewer than 1000 pills containing acetaminophen in their lifetime were used for reference, the odds ratio was 2.0 (95 percent confidence interval, 1.3 to 3.2) for those who had taken 1000 to 4999 pills and 2.4 (95 percent confidence interval, 1.2 to 4.8) for those who had taken 5000 or more pills. Approximately 8 to 10 percent of the overall incidence of ESRD was attributable to acetaminophen use. A cumulative dose of 5000 or more pills containing NSAIDs was also associated with an increased odds of ESRD (odds ratio, 8.8), but the use of aspirin was not. CONCLUSIONS: People who often take acetaminophen or NSAIDs have an increased risk of ESRD, but not those who often take aspirin.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chronic paracetamol use also causes renal damage; a case-control study of 1,077 frequent users found a dose-dependent relationship between heavier paracetamol use and increased risk of end-stage renal disease.
“Renal damage is also produced by chronic use of paracetamol; in a case-control study involving 1,077 subjects who frequently took paracetamol, a dose-dependent relationship between heavier paracetamol use and an increased risk of end-stage renal disease was demonstrated (160).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [160]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305 · see citing works
Estimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214 · see citing works
Best Subsets Logistic Regression
Hosmer, D. W., Jovanovic, B. D., & Lemeshow, S. A. (1989) · Biometrics · doi:10.2307/2531779 · Cited by 1,175 · see citing works
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 977 · see citing works
Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular Disease
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F. R., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329 · see citing works
Analgesic Use and Chronic Renal Disease
Sandler, D. P., Smith, J. C., Weinberg, C. R., Buckalew, V. M., Dennis, V. W., Blythe, W. B., & Burgess, W. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905113201903 · Cited by 254 · see citing works
Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213 · see citing works
Renal Effects of Ibuprofen, Piroxicam, and Sulindac in Patients with Asymptomatic Renal Failure
Whelton, A., Stout, R. L., Spilman, P. S., & Klassen, D. K. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-568 · Cited by 203 · see citing works
An Epidemiologic Study of Abuse of Analgesic Drugs
Dubach, U. C., ROSNER, B. A., & Stürmer, T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240304 · Cited by 123 · see citing works
Regular Analgesic Intake and the Risk of End-Stage Renal Failure
Pommer, W., Bronder, E., Greiser, E. M., Helmert, U., dagger, H. J. J., Klimpel, A., Borner, K., & Molzahn, M. (2008) · American Journal of Nephrology · doi:10.1159/000168002 · Cited by 111 · see citing works
End‐stage renal disease and non‐narcotic analgesics: a case‐control study.
Morlans, M., Laporte, J., Vidal, X., CABEZA, D., & Pd, S. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03841.x · Cited by 99 · see citing works
RELIABILITY OF DRUG HISTORY IN ANALGESIC USERS
Schwarz, A., Faber, U., Borner, K., Keller, F., Offermann, G., & Molzahn, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91608-8 · Cited by 30 · see citing works
Analgesic and NSAID-induced kidney disease
Stewart, J. H. (1993) · Cited by 22 · see citing works
Epidemiologic study of regular analgesic use and end-stage renal disease
Murray, T. G. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.9.1687 · Cited by 20 · see citing works
Effectiveness of the Waksberg Telephone Sampling Method for the Selection of Population Controls
Perneger, T., Myers, T. L., Klag, M. J., & Whelton, P. K. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116898 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [1]1. Spühler O, Zollinger HU. Die chronisch-interstitielle Nephritis. Z Klin Med 1953;151:1-50.
Cited by
Sorted by citations
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530 · see citing works
Chronic kidney disease: the global challenge
Nahas, A. M. E., & Bello, A. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17789-7 · Cited by 1,195 · see citing works
Guidelines for the medical management of osteoarthritis
Hochberg, M. C., Altman, R. D., Brandt, K. D., Clark, B. M., Dieppe, P. A., Griffin, M. R., Moskowitz, R. W., & Schnitzer, T. J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381103 · Cited by 966 · see citing works
Risk factors for chronic kidney disease: an update
Kazancıoğlu, R. (2013) · Kidney International Supplements · doi:10.1038/kisup.2013.79 · Cited by 718 · see citing works
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 654 · see citing works
Brandow, A. M., Carroll, C. P., Creary, S. E., Edwards, R., Glassberg, J., Hurley, R. W., Kutlar, A., Seisa, M. O., Stinson, J., Strouse, J. J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001851 · Cited by 470 · see citing works
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Arancibia‐Hernández, Y. L., Cruz, E. Y. H., & Pedraza‐Chaverrí, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 406 · see citing works
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 368 · see citing works
Garg, A. X., KIBERD, B. A., Clark, W. F., Haynes, R. B., & Clase, C. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00356.x · Cited by 355 · see citing works
Drug-associated renal dysfunction and injury
Choudhury, D., & Ahmed, Z. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0076 · Cited by 345 · see citing works
Oral and Dental Aspects of Chronic Renal Failure
Proctor, R., Kumar, N., Stein, A., Moles, D. R., & Porter, S. R. (2005) · Journal of Dental Research · doi:10.1177/154405910508400301 · Cited by 344 · see citing works
Risk of developing end-stage renal disease in a cohort of mass screening
Iseki, K., Iseki, C., Ikemiya, Y., & Fukiyama, K. (1996) · Kidney International · doi:10.1038/ki.1996.111 · Cited by 340 · see citing works
NSAID Use and Progression of Chronic Kidney Disease
Gooch, K. L., Culleton, B. F., Manns, B., Zhang, J., Alfonso, H. S., Tonelli, M. A., Frank, C., Klarenbach, S. W., & Hemmelgarn, B. R. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.015 · Cited by 333 · see citing works
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Chan, A. T., Manson, J. E., Albert, C. M., Chae, C. U., Rexrode, K. M., Curhan, G. C., Rimm, E. B., Willett, W. C., & Fuchs, C. S. (2006) · Circulation · doi:10.1161/circulationaha.105.595793 · Cited by 317 · see citing works
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · see citing works
Long‐term adverse effects of paracetamol – a review
McCrae, J. C., Morrison, E. E., MacIntyre, I. M., Dear, J. W., & Webb, D. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13656 · Cited by 308 · see citing works
Around-the-Clock, Controlled-Release Oxycodone Therapy for Osteoarthritis-Related Pain
Roth, S. H., Fleischmann, R., Burch, F., Dietz, F., Bockow, B. I., Rapoport, R. J., Rutstein, J. E., & Lacouture, P. G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.853 · Cited by 305 · see citing works
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Hörl, W. H. (2010) · Pharmaceuticals · doi:10.3390/ph3072291 · Cited by 298 · see citing works
Drug-Induced Nephrotoxicity and Its Biomarkers
Kim, S. Y., & Moon, A. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.3.268 · Cited by 289 · see citing works
Acetaminophen, Aspirin, and Chronic Renal Failure
Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C., Blot, W. J., McLaughlin, J. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010323 · Cited by 289 · see citing works
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores.
Taal, M., & Brenner, B. (2006) · Kidney International · doi:10.1038/sj.ki.5001794 · Cited by 285 · see citing works
Clinical practice guideline on pregnancy and renal disease
Wiles, K., Chappell, L. C., Clark, K., Elman, L., Hall, M., Lightstone, L., Mohamed, G., Mukherjee, D., Nelson‐Piercy, C., Webster, P., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1560-2 · Cited by 292 · see citing works
Baker, M. L., & Perazella, M. A. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.03.023 · Cited by 250 · see citing works
Lai, M., Wang, S., Chen, P., Chen, Y., & Wang, J.-D. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp467 · Cited by 233 · see citing works
A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee
Berman, B. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.4.346 · Cited by 225 · see citing works
The global challenge of chronic kidney disease
Nahas, M. E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00774.x · Cited by 200 · see citing works
Paulose‐Ram, R., Hirsch, R., Dillon, C. F., Losonczy, K. G., Cooper, M., & Ostchega, Y. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.755 · Cited by 198 · see citing works
Guidelines for monitoring drug therapy in rheumatoid arthritis
American College of Rheumatology AD Hoc Committee on Clinical Guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390503 · Cited by 193 · see citing works
The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations
Bennett, W. M., Henrich, W. L., & Stoff, J. S. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90570-3 · Cited by 190 · see citing works
Oyelade, T., Alqahtani, J. S., & Canciani, G. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5020080 · Cited by 189 · see citing works
DENTAL CONSIDERATIONS FOR THE PATIENT WITH RENAL DISEASE RECEIVING HEMODIALYSIS
Rossi, S. S. D., & Glick, M. (1996) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1996.0171 · Cited by 184 · see citing works
Confounding by Indication in Epidemiologic Studies of Commonly Used Analgesics
Signorello, L. B., McLaughlin, J. K., Lipworth, L., Friis, S. R., Sørensen, H. T., & Blot, W. J. (2002) · American Journal of Therapeutics · doi:10.1097/00045391-200205000-00005 · Cited by 178 · see citing works
Simms, R. W., Kwoh, C. K., Anderson, L. G., Erlandson, D. M., Greene, J. M., Kelleher, M. E., O’Dell, J. R., Partridge, A. J., Roberts, W. N., Robbins, M. L., et al. (1996) · PubMed · Cited by 178 · see citing works
Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs
Hernández–Dı́az, S., & García‐Rodríguez, L. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00682-3 · Cited by 175 · see citing works
Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in Women
Curhan, G. C., Knight, E. L., ROSNER, B. A., Hankinson, S. E., & Stampfer, M. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1519 · Cited by 165 · see citing works
Massage Therapy for Osteoarthritis of the Knee
Perlman, A. I. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2533 · Cited by 161 · see citing works
Nefropatía terminal en pacientes de un hospital de referencia en El Salvador
Gárcía-Trabanino, R., Aguilar, R., Silva, C. R., Mercado, M. O., & Merino, R. L. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002000900009 · Cited by 160 · see citing works
Pharmacologic treatments for temporomandibular disorders
Dionne, R. A. (1997) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(97)90104-9 · Cited by 158 · see citing works
Herbal medicines for the treatment of osteoarthritis: a systematic review
Long, L., Soeken, K. L., & Ernst, E. (2001) · Lara D. Veeken · doi:10.1093/rheumatology/40.7.779 · Cited by 155 · see citing works
Antidepressants and suicide: what is the balance of benefit and harm
Gunnell, D., & Ashby, D. (2004) · BMJ · doi:10.1136/bmj.329.7456.34 · Cited by 150 · see citing works
Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review
Nderitu, P., Doos, L., Jones, P. W., Davies, S. J., & Kadam, U. T. (2013) · Family Practice · doi:10.1093/fampra/cms086 · Cited by 149 · see citing works
Paracetamol-Induced Renal Tubular Injury
Lorz, C., Justo, P., Sanz, A. B., Subirá, D., Egido, J., & Ortíz, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000111289.91206.b0 · Cited by 149 · see citing works
Drugs for pain management in dentistry
Hargreaves, K., & Abbott, P. V. (2005) · Australian Dental Journal · doi:10.1111/j.1834-7819.2005.tb00378.x · Cited by 146 · see citing works
Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease
Li, Z., Polhemus, D. J., & Lefer, D. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311134 · Cited by 142 · see citing works
The efficacy of combination analgesic therapy in relieving dental pain
MEHLISCH, D. R. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0300 · Cited by 141 · see citing works
De Broe, M. E., & Elseviers, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380707 · Cited by 139 · see citing works
Nonsteroidal Anti-inflammatory Drugs and the Risk of Hospitalization for Acute Renal Failure
Perez‐Gutthann, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440200041005 · Cited by 141 · see citing works
Nonsteroidal Antiinflammatory Drugs as a Trigger of Clinical Heart Failure
Rodríguez, L. A. G., & Hernández–Dı́az, S. (2003) · Epidemiology · doi:10.1097/01.ede.0000034633.74133.c3 · Cited by 138 · see citing works
Risk of End-stage Renal Disease Associated with Alcohol Consumption
Perneger, T., Whelton, P. K., Puddey, I. B., & Klag, M. J. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009958 · Cited by 137 · see citing works
Self-citationStricker, B. H. C., & Stijnen, T. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9451-7 · Cited by 127 · see citing works
Analgesic Use and Renal Function in Men
Rexrode, K. M. (2001) · JAMA · doi:10.1001/jama.286.3.315 · Cited by 122 · see citing works
Plantinga, L., Grubbs, V., Sarkar, U., Hsu, C., Hedgeman, E., Robinson, B. M., Saran, R., Geiss, L. S., Burrows, N. R., Eberhardt, M. S., et al. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1302 · Cited by 117 · see citing works
The genotoxicity and carcinogenicity of paracetamol: a regulatory (re) view
Bergman, K., Müller, L., & Teigen, S. W. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00185-9 · Cited by 116 · see citing works
Perioperative Management of Patients With End-Stage Renal Disease
Kanda, H., Hirasaki, Y., Iida, T., Kanao-Kanda, M., Toyama, Y., Chiba, T., & Kunisawa, T. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.04.019 · Cited by 124 · see citing works
Use and abuse of over-the-counter analgesic agents.
Abbott, F. V., & Fraser, M. I. (1998) · PubMed Central · Cited by 115 · see citing works
Over-the-Counter Analgesics in Older Adults
Roumie, C. L., & Griffin, M. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421080-00001 · Cited by 114 · see citing works
ISFM and AAFP Consensus Guidelines: Long-Term use of NSAIDs in Cats
Sparkes, A., Heiene, R., Lascelles, B. D. X., Malík, R., Sampietro, L. R., Robertson, S. A., Scherk, M. A., & Taylor, P. M. (2010) · Journal of Feline Medicine and Surgery · doi:10.1016/j.jfms.2010.05.004 · Cited by 112 · see citing works
Möller, B., Pruijm, M. T., Adler, S., Scherer, A., Villiger, P. M., & Finckh, A. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204078 · Cited by 113 · see citing works
Regular use of analgesics is a risk factor for renal cell carcinoma
Gago-Domínguez, M., Yuan, J.-M., Castelao, J. E., Ross, R. K., & Yu, M. C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690728 · Cited by 110 · see citing works
Risk of end-stage renal disease associated with gout: a nationwide population study
Yu, K., Kuo, C., Luo, S., See, L., Chou, I., Chang, H.-C., & Chiou, M. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3806 · Cited by 108 · see citing works
Paulose‐Ram, R., Hirsch, R., Dillon, C. F., & Gu, Q. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.983 · Cited by 98 · see citing works
(2008) · Arthritis Care & Research · doi:10.1002/art.23929 · Cited by 98 · see citing works
Lai, M., Lai, J., Chen, P., Hsieh, S.-C., Hu, F.-C., & Wang, J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.10.055 · Cited by 96 · see citing works
Ejaz, P., Bhojani, K. S., & Joshi, V. (2004) · PubMed · Cited by 93 · see citing works
Agodoa, L. Y. C., & Eggers, P. W. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00350.x · Cited by 93 · see citing works
Nonsteroidal Anti-Inflammatory Drugs and Corticosteroids for The Management of Canine Osteoarthritis
Johnston, S. A., & Budsberg, S. C. (1997) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(97)50083-0 · Cited by 91 · see citing works
Ferrell, B. A. (2003) · Springer eBooks · doi:10.1007/0-387-22621-4_28 · Cited by 90 · see citing works
A review of the toxicology presence and removal of ketoprofen through adsorption technology
Georgin, J., Franco, D. S. P., Martinello, K. D. B., Lima, E. C., & Silva, L. F. O. (2022) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2022.107798 · Cited by 89 · see citing works
Use of Nonsteroidal Anti-Inflammatory Drugs Following Exercise-Induced Muscle Injury
Lanier, A. B. (2003) · Sports Medicine · doi:10.2165/00007256-200333030-00002 · Cited by 88 · see citing works
Hsu, P.-C., Tsai, Y., Lai, J., Wu, C., Lin, S., & Huang, C. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.08.029 · Cited by 86 · see citing works
Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection
Polisson, R. P. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89544-7 · Cited by 86 · see citing works
Analgesic use and chronic renal failure: A critical review of the epidemiologic literature
McLaughlin, J. K., Lipworth, L. P., Chow, W., & Blot, W. J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00043.x · Cited by 85 · see citing works
A Benefit-Risk Assessment of Caffeine as an Analgesic Adjuvant
Zhang, W. (2001) · Drug Safety · doi:10.2165/00002018-200124150-00004 · Cited by 85 · see citing works
Ingrasciotta, Y., Sultana, J., Giorgianni, F., Fontana, A., Santangelo, A., Tari, D. U., Santoro, D., Arcoraci, V., Perrotta, M., Ibáñez, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122899 · Cited by 84 · see citing works
Analgesic use and the risk for progression of chronic kidney disease
Kuo, H., Tsai, S., Tiao, M., Liu, Y., Lee, I., & Yang, C. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1962 · Cited by 83 · see citing works
Cabassi, A., Tedeschi, S., Perlini, S., Verzicco, I., Volpi, R., Gonzi, G., & Canale, S. D. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319848105 · Cited by 81 · see citing works
Ma, S., Song, W., Xu, Y., Si, X., Zhang, D., Lv, S., Yang, C., Ma, L., Tang, Z., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119676 · Cited by 81 · see citing works
The clinical spectrum of tubulointerstitial nephritis
Rastegar, A., & Kashgarian, M. J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00001.x · Cited by 80 · see citing works
Analgesic use and change in kidney function in apparently healthy men
Kurth, T., Glynn, R. J., Walker, A. M., Rexrode, K. M., Buring, J. E., Stampfer, M. J., Hennekens, C. H., & Gaziano, J. M. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00647-4 · Cited by 79 · see citing works
Rohla, M., Weiss, T. W., Pecen, L., Patti, G., Siller-Matula, J. M., Schnabel, R. B., SCHILLING, R. J., Kotecha, D., Lucerna, M., Huber, K., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022478 · Cited by 84 · see citing works
Lai, M., Lai, J., Chen, P., Tseng, W., CHEN, Y., Hwang, J., & WANG, J. (2008) · Nephrology · doi:10.1111/j.1440-1797.2008.01061.x · Cited by 78 · see citing works
Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs
Dieppe, P. A., Bartlett, C., Davey, P., Doyal, L., & Ebrahim, S. B. J. (2004) · BMJ · doi:10.1136/bmj.329.7456.31 · Cited by 78 · see citing works
Chrysohoou, C. A., Panagiotakos, D. B., Pitsavos, C. E., Skoumas, J., Zeimbekis, A., Kastorini, C.-M., & Stefanadis, C. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2009.08.006 · Cited by 77 · see citing works
Complementary and alternative medicine in early-stage breast cancer
Tagliaferri, M. A., Cohen, I., & Tripathy, D. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90049-1 · Cited by 76 · see citing works
Rousseau, P. C. (1995) · Disease-a-Month · doi:10.1016/s0011-5029(95)90103-5 · Cited by 77 · see citing works
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2008) · PubMed · Cited by 75 · see citing works
Nelson, D. A., Marks, E. S., Deuster, P. A., O’Connor, F. G., & Kurina, L. M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7896 · Cited by 74 · see citing works
(1998) · JAMA · doi:10.1001/jama.280.18.1636 · Cited by 74 · see citing works
Elseviers, M. M., Schepper, A. D., Corthouts, R., Bosmans, J., Cosyn, L., Lins, R. L., Lornoy, W., Matthys, E. G. J., Roose, R., D, V. C., et al. (1995) · Kidney International · doi:10.1038/ki.1995.416 · Cited by 72 · see citing works
Pahor, M., Guralnik, J. M., Wan, J. Y., Ferrucci, L., Penninx, B. W. J. H., Lyles, A., Ling, S. M., & Fried, L. P. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.6.930 · Cited by 71 · see citing works
Patterns of Opioid Analgesic Prescription Among Patients with Osteoarthritis
Dominick, K. L., Bosworth, H. B., Dudley, T. K., Waters, S. J., Campbell, L. C., & Keefe, F. J. (2004) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v18n01_03 · Cited by 69 · see citing works
Molecular pathways driving omeprazole nephrotoxicity
Fontecha‐Barriuso, M., Martín‐Sánchez, D., Martinez-Moreno, J. M., Cárdenas-Villacrés, D. E., Carrasco, S., Sánchez-Niño, M. D., Ruiz‐Ortega, M., Ortíz, A., & Sanz, A. B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101464 · Cited by 70 · see citing works
Launay‐Vacher, V., Karie, S., Fau, J., Izzedine, H., & Deray, G. (2005) · Journal of Pain · doi:10.1016/j.jpain.2004.11.009 · Cited by 68 · see citing works
Recreational drug use: A neglected risk factor for end-stage renal disease
Perneger, T., Klag, M. J., & Whelton, P. K. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.25181 · Cited by 68 · see citing works
Self-citationPharmacological Treatments for Persistent Non-Malignant Pain in Older Persons
Nikolaus, T., & Zeyfang, A. (2004) · Drugs & Aging · doi:10.2165/00002512-200421010-00003 · Cited by 66 · see citing works
Acetaminophen, aspirin and progression of advanced chronic kidney disease
Evans, M., Fored, C. M., Bellocco, R., Fitzmaurice, G. M., Fryzek, J. P., McLaughlin, J. K., Nyrén, O., & Elinder, C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn745 · Cited by 66 · see citing works
A Review of Epidemiologic Studies of Nonnarcotic Analgesics and Chronic Renal Disease
Delzell, E., & Shapiro, S. (1998) · Medicine · doi:10.1097/00005792-199803000-00003 · Cited by 66 · see citing works
Over-the-Counter Analgesic Use
Broe, M. E. D., & Elseviers, M. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101097 · Cited by 64 · see citing works
Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms
Kennon‐McGill, S., & McGill, M. R. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.201703.005 · Cited by 64 · see citing works
Relationship between nonphenacetin combined analgesics and nephropathy: A review
Feinstein, A. R., Heinemann, L. A. J., Curhan, G. C., Delzell, E., DeSchepper, P. J., Fox, J. M., Graf, H., Luft, F. C., Michielsen, P., Mihatsch, M. J., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00410.x · Cited by 63 · see citing works
- Authors
- Perneger, T. V., Whelton, P. K., & Klag, M. J.
- Affiliations
- University of Geneva (CH)
- Johns Hopkins University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-12-22
- Volume
- 331
- Issue
- 25
- Pages
- 1675-1679
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2320758398
- Cited by
- 484
- References
- 15
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 18 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 21 · 2019: 19 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 17 · 2014: 17 · 2013: 20 · 2012: 20
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (R03-HS06978-01)
- National Center for Research Resources (5MOIRR00722, RR 00035)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Nephrotoxicity and Medicinal Plants
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- end-stage renal disease, renal failure, paracetamol, aspirin, nonsteroidal anti-inflammatory drugs, analgesic use, dose-response relationship, attributable risk, drug-induced nephrotoxicity
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Drug Utilization, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Causality, Confidence Intervals, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review